Author Archive: Jason Corum

Jason Corum

Jason is the director of web and new media with the Biotechnology Industry Organization (BIO). Prior to joining BIO in March 2011, he was the online communications manager for World Food Program USA and an online communications specialist with the Brookings Institution.

Jason is originally from Evergreen Park, Ill. and still thinks that Chicago is the best food city in the nation.  He spends his free time volunteering with the DC Books to Prisons Project, watching movies and reading comics.

Latest Posts

Rare Disease Day 2014: Joining Together for Better Care

Hans Schikan of Prosensa

There are more than 6,000 different rare diseases affecting over 60 million people across Europe and North America, alone, and millions more throughout the world. Most of these diseases are genetic, serious, chronic and debilitating. Each disease is different, but they affect people in similar ways. Joining together can help patients and their families find common solutions for care and remind them they are not alone. As the world marks Rare Disease Day on February Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Participate in the 11th Annual Biopharmaceutical Manufacturing Report and Survey

Participate in the biopharmaceutical manufacturing industry’s most in-depth, global study: 11th Annual Biopharmaceutical Manufacturing Report and Survey. Your input is more important than ever, as BioPlan Associates benchmarks global and regional trends affecting the industry. You will receive a free summary of the results of the study as well as BioPlan’s 159 Key Industry Facts White Paper. For each completed survey BioPlan will donate $10 (up to $10,000) to global health charities. The survey takes Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

Jim Greenwood

In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John J. Castellani, president of PhRMA, write that context must accompany the data being provided under the Physician Payments Sunshine Act: “Discovery of new and improved medicines would be impossible without collaborations between physicians and biopharmaceutical companies. Consider ongoing research and clinical trials that not only make medicines possible, but also help our understanding of disease. Biopharmaceutical professionals help physicians stay Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

Dent

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, co- chair of the Congressional Biomedical Research Caucus, joined BIO’s Fritz Bittenbender to discuss the biotech industry in Pennsylvania as well as recent legislative developments affecting the industry. Dent points to the recent omnibus spending agreement which allowed the Food and Drug Administration (FDA) to access user $85 million in user fees sequestered in 2013. These fees are paid to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

4 Tips for Building a Successful Biotech: Richard Pops of Alkermes at #BIOCEO14

Pops

The 16th Annual BIO CEO & Investor Conference opened with a fireside chat between Richard F. Pops, Chairman & Chief Executive Officer of Alkermes, and David Gluckman of Lazard. The candid discussion gave biotech CEOs a peek in to the story of Alkermes, yielding useful guidance on building a successful, agile company ready for a changing marketplace. Here are some of the highlights: Be world class in a specific area of science. “In our company, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,